Wet Age-Related Macular Degeneration (Wet AMD) Pipeline Landscape Research 2024
November 22, 2024 07:10 ET
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The emergent...
Age-Related Macular Degeneration (AMD) Drugs Market Research 2024: Lucentis, Eylea, Eylea HD, Vabysmo, Syfovre, Ranibizumab, Aflibercept, Faricimab, Biologic, Biosimilar - Global Forecast to 2029
November 08, 2024 11:26 ET
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept,...
Dry Age-related Macular Degeneration (Dry-AMD) Drug Pipeline Insight Landscape Report 2024: Comprehensive Insights About 70+ Companies and 80+ Pipeline Drugs
March 01, 2024 08:54 ET
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Dry Age-related Macular Degeneration (Dry-AMD) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...